Recalled hypertension drug not linked to increased short-term cancer risk

Researchers and regulators have performed an expedited analysis of the recently recalled valsartan products amid emerging public health concerns.
Researchers and regulators have performed an expedited analysis of the recently recalled valsartan products amid emerging public health concerns.